Options Spotlight: Schering-Plough Corporation
This week’s edition of Options Spotlight takes a look at Schering-Plough Corporation
(
SGP |
Quote |
Chart |
News |
PowerRating).
According to Hoover’s, the pharmaceuticals giant makes prescription and over-the-counter (OTC) drugs, animal health products, and personal care products. Although it is best known for allergy medications Clarinex and Nasonex, the firm also specializes in anti-infectives and cancer drugs. Additionally, it co-promotes erectile dysfunction pill Levitra in the U.S. with GlaxoSmithKline and cholesterol drug Vytorin with Merck.
Schering-Plough’s OTC offerings include Claritin allergy pills, Afrin nasal sprays, Dr. Scholl’s foot-care products, and sun-care lines Coppertone and Bain de Soleil.
In the Options Spotlight, I shine a light on what’s happening in the options world. In the case of Schering-Plough, call activity has been brisk on the shares as investors attempt to call a bottom to the security’s downtrend. Has this stock’s decline finally reached an end?
Newly revised and updated, Bernie Schaeffer’s home study program, “10 Days to Successful Options Trading,” provides a foundation for your options trading success. Includes easy-to-follow guide, CD, DVD, and a special report — Click here to learn more.
Copyright Schaeffer’s Investment Research. www.schaeffersresearch.com.